 for the treatment of people who have early symptoms of Alzheimer's disease. And that also includes cognitive mild impairment and mild dementia. So that's really exciting. We haven't had a drug in that class that would help people in the early stages and who have those confirmed amyloid plaques in their brain. So it's very exciting news to have another medication to help people and to look for the future for hope without this disease. That is excellent. And, uh,